Ours and others’ laboratories have shown that STAT3, a molecular pathway activated by IL-6, released by PEL cells, and via the expression of several viral proteins, plays a crucial role in sustaining the survival and proliferation of Primary Effusion Lymphoma (PEL) [10], an aggressive KSHV-associated lymphoma. This evidence concerns the gene IL6 and lymphoma.